Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia.
about
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemiaAn autism case history to review the systematic analysis of large-scale data to refine the diagnosis and treatment of neuropsychiatric disordersComprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemiaProtectors or Traitors: The Roles of PON2 and PON3 in Atherosclerosis and CancerPON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell deathMLL-rearranged acute lymphoblastic leukaemia stem cell interactions with bone marrow stroma promote survival and therapeutic resistance that can be overcome with CXCR4 antagonismBioinspired multivalent DNA network for capture and release of cells.Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemiaIntegrative Analysis of MicroRNA-Mediated Gene Signatures and Pathways Modulating White Blood Cell Count in Childhood Acute Lymphoblastic Leukemia.Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia.Connective tissue growth factor is expressed in bone marrow stromal cells and promotes interleukin-7-dependent B lymphopoiesis.Regulatory network of GATA3 in pediatric acute lymphoblastic leukemiaRearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemiaSingle molecule analysis of c-myb alternative splicing reveals novel classifiers for precursor B-ALL.Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group.A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALLImmunologic minimal residual disease detection in acute lymphoblastic leukemia: a comparative approach to molecular testingA six gene expression signature defines aggressive subtypes and predicts outcome in childhood and adult acute lymphoblastic leukemiaUnique characteristics of adolescent and young adult acute lymphoblastic leukemia, breast cancer, and colon cancer.Regulator of myeloid differentiation and function: The secret life of Ikaros.Identification of differentially expressed genes associated with prognosis of B acute lymphoblastic leukemia.Vandetanib mediates anti-leukemia activity by multiple mechanisms and interacts synergistically with DNA damaging agents.Gene Expression Profiling of Ewing Sarcoma Tumors Reveals the Prognostic Importance of Tumor-Stromal Interactions: A Report from the Children's Oncology GroupImproving access to novel agents for childhood leukemia.Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study.Apoptosis pathway signature for prediction of treatment response and clinical outcome in childhood high risk B-Precursor acute lymphoblastic leukemia.Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcomeOutcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study.Minimal Residual Disease in AML: Why Has It Lagged Behind Pediatric ALL?Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.Aurora B Overexpression Causes Aneuploidy and p21Cip1 Repression during Tumor Development.Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia.Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia.NF-κB and AKT signaling prevent DNA damage in transformed pre-B cells by suppressing RAG1/2 expression and activityTyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET ProjectClinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemiaIntegrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy.Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcomaAdvances in the Biology of Acute Lymphoblastic Leukemia-From Genomics to the ClinicHigh expression of ID family and IGJ genes signature as predictor of low induction treatment response and worst survival in adult Hispanic patients with B-acute lymphoblastic leukemia.
P2860
Q24597256-EBFD5C40-D5DE-420A-91CC-BA73AAC67B6BQ27008961-C9CF666F-34DE-4A34-9A83-2BA1988A806FQ27853385-C773994F-D811-48AF-90EC-D5E4DBB15C76Q28384857-09F7D2E7-F455-4A9C-9C21-0A9A168FC267Q28387637-1193D7B2-58D5-4282-B946-C4DB64054883Q28658170-5FB9DE37-DE97-45C7-B687-D6B341BABF58Q30528846-7189293B-BF9D-4098-A304-A5F5DEEB892EQ30538418-96EA1C6B-95D7-410D-B440-5A50E1642F6CQ33580638-00B96D6E-408A-4353-884D-7C1299500B37Q33711119-CE09E688-D3F9-4C4C-856B-F52867A76A75Q33828549-852114B9-7983-4D8F-AD91-9171A8B88933Q33829399-C371717D-1150-48B1-AA99-743C2B18404FQ33985127-9D624568-60C1-48C1-88C3-136F5EBFA181Q33996833-D001B80F-F9A4-4403-92FD-EE1FE24E164DQ33998291-7D63D17B-AF6D-4020-B443-ADB78B105E3AQ34217173-C91AABD7-75DF-4DC3-92E7-2821005BAA7BQ34425875-6AAA4B41-3AF7-4622-98FF-572BE4337E20Q34477517-624C3E82-13DB-4EC7-8C5D-13911C7D2DB4Q34820332-250DE7D7-AA67-481C-AA1C-5A08406D9762Q35103926-33A65EDB-BEBD-4580-9ECF-13CC25865F43Q35162503-16F436D9-F613-45DA-98E6-3149EDAF9C62Q35569079-8AD8F56C-F232-464A-9BC9-C208E67DB3D6Q35688154-06D8C5B1-9E09-41C5-ACE8-568D3152E412Q35688742-97693651-6704-4F90-AC3C-0CB121DAAF98Q35802220-E4B1DE7C-4369-415B-9D01-8B269A3BCF57Q35835290-6D153A54-A703-4607-B054-B2235B987993Q35876592-5A926559-2621-4238-BC86-579EA6A9F31DQ35885293-25DB6FCE-3D4B-4301-8E57-827DFE0301EDQ35992927-2CCA1BBA-0359-4BDD-80B9-1FDD710A3A3EQ36058255-0D7EDFC1-BC98-4F9D-A798-FC7F6CE056E4Q36070046-604F7D31-96A9-427D-AB6C-54650A0880D0Q36141916-2FAC27A8-CCB2-42B7-BF13-330D06A56E82Q36143247-AD733778-4B46-43C0-BAD3-09BE04FC006EQ36351111-BA3FE83A-4BFE-4C21-862B-472F568947E2Q36542815-608141D6-31DF-4B24-B444-32E1AF701892Q36561755-67E077CD-460F-4A23-91BD-6EF6E446EC41Q36666787-8B047E5F-4C37-4EE1-8A07-830D229D21E3Q36717196-82591CAD-CDAE-41B5-9D01-D36103CCFC55Q36752634-0CD251EB-6E33-444B-9B22-FA58ECF82B76Q36765731-094C986D-C352-4424-A038-BC75C9523097
P2860
Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Gene expression classifiers fo ...... acute lymphoblastic leukemia.
@ast
Gene expression classifiers fo ...... acute lymphoblastic leukemia.
@en
type
label
Gene expression classifiers fo ...... acute lymphoblastic leukemia.
@ast
Gene expression classifiers fo ...... acute lymphoblastic leukemia.
@en
prefLabel
Gene expression classifiers fo ...... acute lymphoblastic leukemia.
@ast
Gene expression classifiers fo ...... acute lymphoblastic leukemia.
@en
P2093
P2860
P50
P1433
P1476
Gene expression classifiers fo ...... acute lymphoblastic leukemia.
@en
P2093
Bruce M Camitta
Carla S Wilson
Cheryl L Willman
Edward J Bedrick
Gregory H Reaman
Huining Kang
I-Ming Chen
James R Downing
Malcolm A Smith
P2860
P304
P356
10.1182/BLOOD-2009-05-218560
P407
P577
2009-10-30T00:00:00Z